Cognitive Behavioural Therapy for Avoidant/Restrictive Food Intake Disorder (CBT-AR)

Launched by ORYGEN · Jun 13, 2024

Keywords

ClinConnect Summary

This clinical trial, called Cognitive Behavioural Therapy for Avoidant/Restrictive Food Intake Disorder (CBT-AR), is studying a special type of therapy designed for individuals with Avoidant/Restrictive Food Intake Disorder (ARFID). The goal of the trial is to see if this therapy is practical, well-received, and effective in helping patients reduce their ARFID symptoms. Researchers believe that this treatment will be beneficial for patients, their families, and the healthcare professionals involved.

To participate in the study, individuals must be diagnosed with ARFID and receiving treatment at the Orygen Specialist Program for eating disorders. Generally, those eligible are between the ages of 4 and 16, or over 16 but underweight (with a body mass index below 18.5) and living with a parent or guardian, who will need to be involved in their treatment. Participants can expect to engage in therapy sessions aimed at addressing their eating challenges. It's important to note that individuals currently receiving tube feeding or those with more urgent mental health issues may not be suitable for this study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Current primary diagnosis of ARFID according to DSM-5 criteria as determined by the treating team (the eating disorders Orygen Specialist Program
• • Presenting for treatment in the eating disorders Orygen Specialist Program
• • If \<16yo, or \>16 but underweight (BMI \<18.5) and living with their parents/guardian, a parent/guardian should be involved in the treatment.
• Exclusion Criteria:
• • Current tube feeding
• • Inappropriateness for CBT-AR as determined by the clinicians (e.g. if there are more urgent issues to first manage such as high suicidal ideation, if participants do not have adequate comprehension capability, etc)